Literature DB >> 30703481

SIRT5-mediated SDHA desuccinylation promotes clear cell renal cell carcinoma tumorigenesis.

Yuanzhen Ma1, Yijun Qi1, Lei Wang2, Zhaoxu Zheng1, Yue Zhang1, Junfang Zheng3.   

Abstract

Metabolic reprogramming is a prominent feature of clear cell renal cell carcinoma (ccRCC). Protein succinylation influences cell metabolism, but its effects on ccRCC tumorigenesis remain largely uncharacterized. In this study, we investigated the lysine succinylome of ccRCC tissues by using tandem mass tag labeling, affinity enrichment, liquid chromatography-tandem mass spectrometry and integrated bioinformatics analyses. Proteins involved in metabolic process, the tricarboxylic acid (TCA) cycle, oxidation-reduction and transport processes were subject to succinylation. A total of 135 sites in 102 proteins were differentially succinylated between ccRCC and adjacent normal tissues. Succinate dehydrogenase complex subunit A (SDHA), which is involved in both the TCA cycle and oxidative phosphorylation, was desuccinylated at lysine 547 in ccRCC. SDHA desuccinylation by mimetic mutation (K547R) suppressed its activity through the inhibition of succinate dehydrogenase 5 (SDH5) binding, further promoted ccRCC cell proliferation. The desuccinylase sirtuin5 (SIRT5) was found to interact with SDHA, and SIRT5 silencing led to the hypersuccinylation and reactivation of SDHA. SIRT5 was also found to be upregulated in ccRCC tissues, and its silencing inhibited ccRCC cell proliferation. This indicates that SIRT5 promotes ccRCC tumorigenesis through inhibiting SDHA succinylation. This is the first quantitative study of lysine succinylome in ccRCC, through which we identified succinylation in core enzymes as a novel mechanism regulating various ccRCC metabolic pathways. These results expand our understanding about the mechanisms of ccRCC tumorigenesis and highlight succinylation as a novel therapeutic target for ccRCC.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clear cell renal cell carcinoma; Desuccinylation; SDHA; SIRT5; Tumorigenesis

Mesh:

Substances:

Year:  2019        PMID: 30703481     DOI: 10.1016/j.freeradbiomed.2019.01.030

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  18 in total

Review 1.  Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.

Authors:  Wen Li; Feifei Li; Xia Zhang; Hui-Kuan Lin; Chuan Xu
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

2.  Repression of p53 function by SIRT5-mediated desuccinylation at Lysine 120 in response to DNA damage.

Authors:  Xing Liu; Fangjing Rong; Jinhua Tang; Chunchun Zhu; Xiaoyun Chen; Shuke Jia; Zixuan Wang; Xueyi Sun; Hongyan Deng; Huangyuan Zha; Gang Ouyang; Wuhan Xiao
Journal:  Cell Death Differ       Date:  2021-10-12       Impact factor: 12.067

Review 3.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

4.  Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism.

Authors:  Wen-Jie Zhou; Jie Zhang; Hui-Li Yang; Ke Wu; Feng Xie; Jiang-Nan Wu; Yan Wang; Li Yao; Yan Zhuang; Jiang-Dong Xiang; Ai-Jun Zhang; Yin-Yan He; Ming-Qing Li
Journal:  Cell Commun Signal       Date:  2019-08-20       Impact factor: 5.712

Review 5.  Resveratrol's Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism.

Authors:  Aranka Brockmueller; Saba Sameri; Alena Liskova; Kevin Zhai; Elizabeth Varghese; Samson Mathews Samuel; Dietrich Büsselberg; Peter Kubatka; Mehdi Shakibaei
Journal:  Cancers (Basel)       Date:  2021-01-07       Impact factor: 6.639

Review 6.  Serine hydroxymethyltransferase 2: a novel target for human cancer therapy.

Authors:  Min Xie; Dong-Sheng Pei
Journal:  Invest New Drugs       Date:  2021-07-03       Impact factor: 3.850

7.  SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis.

Authors:  Zhiyu Fang; Qiang Sun; Huihui Yang; Junfang Zheng
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

8.  Genomic and Transcriptome Analysis to Identify the Role of the mTOR Pathway in Kidney Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance.

Authors:  Xiangyu Che; Xiaochen Qi; Yingkun Xu; Qifei Wang; Guangzhen Wu
Journal:  Oxid Med Cell Longev       Date:  2021-06-07       Impact factor: 6.543

9.  Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.

Authors:  Guanghua Liu; Jingmin Zhou; Yuanlin Piao; Xin Zhao; Yuzhi Zuo; Zhigang Ji
Journal:  Aging (Albany NY)       Date:  2020-06-15       Impact factor: 5.682

10.  Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma.

Authors:  Ying Tan; Bijuan Li; Fang Peng; Guanghui Gong; Ning Li
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.